| Charles Daniel Stokke, DMD | |
|
116 W 3rd St, Anaconda, MT 59711-2205 | |
| (406) 563-7666 | |
| (406) 563-7666 |
| Full Name | Charles Daniel Stokke |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 116 W 3rd St, Anaconda, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790849768 | NPI | - | NPPES |
| 0113730 | Medicaid | MT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | MT1467 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles Daniel Stokke, DMD 116 W 3rd St, Anaconda, MT 59711-2205 Ph: (406) 563-7666 | Charles Daniel Stokke, DMD 116 W 3rd St, Anaconda, MT 59711-2205 Ph: (406) 563-7666 |
News Archive
Cambrex Corporation announced it has acquired IEP GmbH, a privately held company that is a leader in the field of industrial biocatalysis. IEP is located in Wiesbaden, Germany and offers cost effective customized biocatalytic process development and sales of enzymes to the pharmaceutical industry, with the ability to utilize its tool box of over 100 proprietary biocatalytic enzymes.
Soon children could be vaccinated with bacteria mixed in milk and people in the developing world given unprecedented access to immunisations under a scheme proposed by an Australian Nobel laureate, Barry Marshall.
With about 35 million people around the world suffering from Alzheimer's disease (AD) by the year 2010 and an expectation that these numbers will double every twenty years with approximately 115 million cases by 2050, pressure on healthcare systems worldwide will be intense. In a special issue of the journal Behavioural Neurology, twelve contributions from an international group of researchers discuss imaging techniques that may contribute to early diagnosis and advancements in treatment for this devastating disease.
Klebsiella bacteria cause about 10 percent of all hospital-acquired infections in the United States. K. pneumoniae sequence type 258 (ST258) is one of the Carbapenem-Resistant Enterobacteriaceae organisms labeled an urgent threat by the Centers for Disease Control and Prevention.
Soligenix, Inc., a development stage biopharmaceutical company, announced today the results of a Phase 1B clinical trial of an aluminum hydroxide (Alum) adjuvanted formulation of RiVax, designed to improve the immunogenicity of the vaccine.
› Verified 9 days ago
Mr. Edward J Miller, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 115 W Commercial Ave, Anaconda, MT 59711 Phone: 406-563-6660 Fax: 406-563-2387 | |
Anthony Bartoletti, D.M.D Dentist Medicare: Not Enrolled in Medicare Practice Location: 215 Hickory St, Anaconda, MT 59711 Phone: 406-563-5450 | |
Dr. Edward Antone Bartoletti, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 215 Hickory St, Anaconda, MT 59711 Phone: 406-563-5450 | |
Dr. Katherine A. Sims Slocum, DDS Dentist Medicare: Medicare Enrolled Practice Location: 307 E Park Ave, Suite 308, Anaconda, MT 59711 Phone: 406-563-3473 Fax: 406-563-7557 | |
Dr. Amy K Lowe, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 116 W 3rd St, Anaconda, MT 59711 Phone: 406-563-7666 | |
Dr. Andrew Clark Cromwell, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 315 Oak St, Anaconda, MT 59711 Phone: 406-563-3025 |